<DOC>
	<DOCNO>NCT02657148</DOCNO>
	<brief_summary>The investigator design single site , Phase IV open label , prospective observational clinical trial compare effect immediate postpartum Nexplanon placement ( IPP ) versus standard postpartum contraceptive care ( control ) consistent contraceptive use rapid repeat pregnancy 12 month postpartum 200 opioid dependent ( OD ) woman .</brief_summary>
	<brief_title>Immediate Postpartum Nexplanon Placement Opioid Dependent Women</brief_title>
	<detailed_description>Background : Opioid dependence pregnancy increase dramatically last decade . Over 86 % pregnancy conceive OD woman unintended , compare 31-43 % pregnancy general population . In evaluation contraceptive use among sexually active woman opioid treatment program , 40-75 % sexually active OD woman report contraceptive use . Even among woman use contraception , 45-55 % report use condom without effective , hormonal contraception . Pregnancy postpartum period unique opportunity provide contraceptive education service . Long-acting reversible contraception ( LARC ) show effectively prevent rapid repeat , unintended pregnancy compare postpartum contraceptive option incur risk venous thromboembolism associate estrogen-containing method ( i.e . pill , ring , patch ) . No study evaluate impact immediate postpartum etonogestrel implant ( Nexplanon ) placement reproductive health outcome OD woman , population significant risk rapid repeat , unintended pregnancy . In contrast intrauterine device ( IUD ) , Nexplanon safe insert regardless labor delivery circumstance , incur increase risk postpartum expulsion long-acting , make ideal contraceptive immediate postpartum period . Study site : This single site study conduct Magee-Womens Hospital ( MWH ) University Pittsburgh Medical Center . Study Procedures : Recruitment - participant recruited third trimester pregnancy ( â‰¥ 28 week gestation ) prenatal care visit . Immediate postpartum Nexplanon placement ( IPP ) - participant choose enroll IPP Nexplanon arm Nexplanon place immediate postpartum period ( 2-4 day follow delivery ) , prior hospital discharge . Standard postpartum contraceptive care ( control ) - participant choose enroll control arm receive contraceptive method choice accord standard clinical protocol . Standard clinical protocol include condom , Depo Provera ( DMPA ) progestin-only pill initiated time delivery , Nexplanon insertion &gt; 4 week delivery , combine hormonal contraception ( e. g. pill , patch , ring ) initiate time &gt; 4 week delivery levonorgestrel-intrauterine system copper IUD insertion time &gt; 6 week delivery . Study Duration : 12 month</detailed_description>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Etonogestrel</mesh_term>
	<mesh_term>Desogestrel</mesh_term>
	<criteria>Pregnant woman , 18 year old , meet DSMV criterion opioid use disorder confirm diagnostic coding patient 's medical record and/or urinary toxicology screen ( UDS ) plan deliver study site hospital , MageeWomens Hospital UPMC ( MWHUPMC ) . Women contraindication etonogestrel use , intrauterine fetal demise stillbirth , and/or plan deliver MWHUPMC .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>